Dynasil Corporation of America  

(Public, NASDAQ:DYSL)   Watch this stock  
Find more results for DYSL
+0.01 (0.80%)
Sep 22 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 1.21 - 1.27
52 week 0.89 - 1.50
Open 1.21
Vol / Avg. 5,577.00/32,658.00
Mkt cap 21.50M
P/E 7.15
Div/yield     -
EPS 0.18
Shares 17.06M
Beta 0.02
Inst. own 12%
Aug 14, 2017
Q3 2017 Dynasil Corporation of America Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '17) 2016
Net profit margin -2.42% 0.77%
Operating margin -3.08% 1.56%
EBITD margin - 4.47%
Return on average assets -3.06% 1.31%
Return on average equity -3.17% 4.65%
Employees 233 -
CDP Score - -


313 Washington St Ste 403
NEWTON, MA 02458-1626
United States - Map
+1-617-6686855 (Phone)
+1-617-6686992 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Dynasil Corporation of America is engaged in the development, marketing and manufacturing of detection, sensing and analysis technology and optical components, as well as contract research. The Company operates through three segments, including Contract Research, Optics and Biomedical. The Contract Research segment consists of the Radiation Monitoring Devices, Inc. (RMD) business unit. The Optics segment operates through four business units: Dynasil Fused Silica, Optometrics Corporation, Hilger Crystals, Ltd. and Evaporated Metal Films Corporation, which manufactures commercial products, including optical crystals for sensing in the security and medical imaging markets, as well as optical components, optical coatings and optical materials for scientific instrumentation and other applications. The Biomedical segment consists of a business unit, Dynasil Biomedical Corporation, a medical technology incubator, which owns rights to certain early-stage medical technologies.

Officers and directors

Robert J. Bowdring Chief Financial Officer, Controller
Age: 59
Bio & Compensation  - Reuters
Peter Sulick Chairman of the Board, President, Chief Executive Officer
Age: 65
Bio & Compensation  - Reuters
William K. Hagan Ph.D. Lead Independent Director
Age: 64
Bio & Compensation  - Reuters
Craig T. Dunham Independent Director
Age: 60
Bio & Compensation  - Reuters
Lawrence Joseph Fox Independent Director
Age: 73
Bio & Compensation  - Reuters
David Kronfeld Independent Director
Age: 68
Bio & Compensation  - Reuters
Alan B. Levine CPA Independent Director
Age: 72
Bio & Compensation  - Reuters